NanoVibronix logo
NanoVibronix
NAOV | NASDAQ
Chart Builder DCF Calculator
$1.90
+$0.02 (+1.06%)
At close: Mar 11, 2026, 09:30 AM ET

NanoVibronix Company Profile

Company profile explained

Company Profile

NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain. Key among their product line is UroShield, an ultrasound-based solution engineered to deter bacterial colonization and biofilm development in urinary catheters, thereby boosting antibiotic efficacy and reducing associated patient discomfort. They also offer PainShield and WoundShield, both patch-based therapeutic ultrasound technologies. PainShield targets relief from pain, muscle spasms, and joint contractures, while WoundShield is designed to foster tissue regeneration and promote healing in wounds. The company distributes these products directly to consumers and via extensive distributor networks spanning the United States, Israel, Europe, India, and numerous other international regions. Founded in 2003, NanoVibronix, Inc. maintains its corporate headquarters in Elmsford, New York.

Key Executives

Name Position
Doron Robert Besser Chief Executive Officer & Director
Stephen R. Brown Chief Financial Officer
Harold Jacob Chief Medical Officer
Lindsey Harrison Vice President of Sales
Rita Silberberg Executive Vice President of Finance, Chief Accounting Officer & Corporate Secretary

Latest SEC Filings

Date Type Title
Sep 03, 2026 EFFECT Filing
Aug 31, 2026 8-K Current Report
Aug 17, 2026 10-Q Quarterly Report
Aug 14, 2026 NT 10-Q Filing
Aug 14, 2026 8-K Current Report
Aug 12, 2026 8-K Current Report
Aug 10, 2026 S-3 Filing
Jul 24, 2026 DEF 14A Filing
Jul 14, 2026 PRE 14A Filing
Jul 14, 2026 8-K Current Report
View All SEC Filings ➞
NanoVibronix
NanoVibronix logo
Country United States
IPO Date May 28, 2015
Industry Medical - Devices
Sector Healthcare
Employees 31
CEO Doron Robert Besser

Contact Details

525 Executive Boulevard Elmsford, New York 10523 United States

Stock Details

Ticker Symbol NAOV
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001326706
CUSIP Number 63008J884
ISIN Number US63008J8844
SIC Code 3842

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.